This concentration should be sufficient to inhibit P‐selectin‐mediated platelet–monocyte aggregate formation, as it was higher than the in vivo concentration that inhibited platelet–monocyte aggregate formation by ≈30% in a canine thrombosis model (unpublished observations). The gene discussed is SELP; the disease is deep vein thrombosis.